MetaCap

Amneal Pharmaceuticals Inc. Class A (AMRX)

NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.12-0.27 (-1.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AMRX stock chart

Technical analysis

Key statistics

All statistics
52-week range
11.71 – 22.13
Day range
21.07 – 21.70
Volume / Avg
1.67M / 3.16M
Beta
—

52-week range

$11.71$22.13

AMRX stock today

Amneal Pharmaceuticals (AMRX) closed at $21.12 on Nov 20, down 1.26% (-$0.27), versus the S&P 500's 3.70% decline. At this level, AMRX sits near the top of its 52-week range of $11.71 to $22.13: 4.5% below the high, set on Nov 18, 2026 and 80.4% above the low. AMRX is up 67.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 76.7%.

At 52.8x trailing earnings, Amneal Pharmaceuticals trades above the peer-group median of 47.8x. Its forward P/E of 17.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Amneal Pharmaceuticals

Company profile

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Chirag K. Patel
Headquarters
Bridgewater, NJ
Employees
8,700
Website
amneal.com

Financial highlights

Full financials

In fiscal 2025, Amneal Pharmaceuticals generated $3.02 billion in revenue, up 8.0% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $72.1 million, for a net margin of 2.4% versus a median of -3.5% in the prior 5 years. Gross margin was 36.9% (up from 36.5%) and operating margin 13.1%.

Amneal Pharmaceuticals annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.02B$2.79B$2.39B$2.21B$2.09B
Growth+8.05%+16.73%+8.20%+5.67%+5.08%
Net income$72.06M$-116.89M$-83.99M$-270.58M$13.16M
EPS (diluted)$0.22$-0.38$-0.48$-0.86$0.07

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$24.29+15.01%

  • Strong buy 3
  • Buy 4
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $20.00High $28.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$0.15 vs $0.23
Surprise
-34.78%

AMRX news

All AMRX news

Amneal Pharmaceuticals peers

Health Care sector
AMRX peer companies
CompanyPrice% ChgMarket capCompare
KNSAKiniksa Pharmaceuticals International plc Class A93.90+0.38%$7.38Bvs AMRX
ALKSAlkermes plc44.94-2.69%$7.55Bvs AMRX
RYTMRhythm Pharmaceuticals Inc.112.36-3.80%$7.79Bvs AMRX
CYTKCytokinetics Incorporated50.78-1.32%$7.07Bvs AMRX
PTGXProtagonist Therapeutics Inc.121.40-2.11%$7.92Bvs AMRX
CORTCorcept Therapeutics Incorporated63.62-2.09%$6.96Bvs AMRX
SMMTSummit Therapeutics Inc.9.95-5.87%$7.96Bvs AMRX
AXSMAxsome Therapeutics Inc.129.36-4.66%$6.80Bvs AMRX

Indexes, lists and sector

Amneal Pharmaceuticals stock FAQ

What is Amneal Pharmaceuticals's stock price today?

AMRX last traded at $21.12 as of Nov 20, 4:00 PM EST, down 1.26% on the day. Prices are delayed at least 15 minutes.

What is AMRX's P/E ratio?

AMRX trades at a trailing P/E ratio of 52.80 and a forward P/E of 17.13, compared with a median of 47.8 for its closest peers.

Who is Amneal Pharmaceuticals's CEO?

Mr. Chirag K. Patel is the chief executive officer of Amneal Pharmaceuticals Inc. Class A, which has about 8,700 employees.

What is the AMRX 52-week high?

The 52-week high for AMRX is $22.13 and the 52-week low is $11.71. The stock is currently 4.5% below its high.

Compare AMRX